CCCristóbal Cuadrado

Cristóbal Cuadrado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cristóbal Cuadrado has a total of 180 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Reproducible Data Lakehouse for High-Resolution Gastric Cancer Epidemiology Study in Chile

    by Rene Lagos, Cristóbal Cuadrado, Francisca Jofré, Arnoldo Riquelme

    Add a two sentence description about your article.

  • Utility Values of Health Status in Gastric Cancer: A Systematic Review

    by Cristian Gonzalez, Manuel Espinoza, Matías Libuy, Francisca Crispi, Arnoldo Riquelme, Fernando Alarid-Escudero, Gonzalo Latorre, Margarita Pizarro, Cristóbal Cuadrado


  • Efficiency of periodontal treatment to improve type 2 diabetes mellitus outcomes: A systematic review and meta‐analysis of economic evaluations

    by Gustavo Sáenz‐Ravello, Marianela Castillo‐Riquelme, Cristóbal Cuadrado, Jorge Gamonal, Mauricio Baeza

    Background: To assess the efficiency of periodontal treatment (PT) in improving diabetes‐related outcomes in adults with type 2 diabetes mellitus (T2DM) and periodontitis, providing an updated and comprehensive synthesis from economic evaluations (EE).Methods: Seven databases and one register were independently searched by two reviewers for articles published up to 8 May 2024. Studies that assessed the efficiency of PT versus no treatment or other dental treatments were included. Risk of bias was assessed using the Cochrane RoB 2, ROBINS‐I and ECOBIAS tools for the first stage of EE and the CHEERS checklist and NICE quality appraisal tool for overall EE. Qualitative and quantitative syntheses of the articles were conducted and assessed using the GRADE approach.Results: Eleven studies were included. PT reduces total healthcare costs, including inpatient and outpatient, diabetes‐related costs and other drug costs (low to moderate certainty). A total incremental net benefit of USD 12 348 (2022 currency, 95% CI 12 195–12 500) was estimated from three high‐quality model‐based cost‐utility analyses (high certainty).Discussion: The inclusion of PT in the comprehensive treatment of patients with T2DM and periodontitis is cost‐effective. Future research is required to ensure the transferability of these findings and inform decision makers from different countries.Registration: PROSPERO CRD42023443146.


  • Open Access

    Nowcasting methods to improve the performance of respiratory sentinel surveillance: lessons from the COVID-19 pandemic

    by Sandra Flores-Alvarado, María Fernanda Olivares, Natalia Vergara, Christian García, Mauricio Canals, Cristóbal Cuadrado

    Respiratory diseases, including influenza and coronaviruses, pose recurrent global threats. This study delves into the respiratory surveillance systems, focusing on the effectiveness of SARI sentinel surveillance for total and severe cases incidence estimation. Leveraging data from the COVID-19 pandemic in Chile, we examined 2020–2023 data (a 159-week period) comparing census surveillance results of confirmed cases and hospitalizations, with sentinel surveillance. Our analyses revealed a consistent underestimation of total cases and an overestimation of severe cases of sentinel surveillance. To address these limitations, we introduce a nowcasting model, improving the precision and accuracy of incidence estimates. Furthermore, the integration of genomic surveillance data significantly enhances model predictions. While our findings are primarily focused on COVID-19, they have implications for respiratory virus surveillance and early detection of respiratory epidemics. The nowcasting model offers real-time insights into an outbreak for public health decision-making, using the same surveillance data that is routinely collected. This approach enhances preparedness for emerging respiratory diseases by the development of practical solutions with applications in public health.


  • Open Access

    Impact of Total Indoor Smoking Ban on Cardiovascular Disease Hospitalizations and Mortality: The Case of Chile

    by Daniela Montes de Oca, Guillermo Paraje, Cristóbal Cuadrado

    The harmful effects of first and secondhand smoking are well-established. Smoke-free laws aim at protecting nonsmokers. This study aimed to assess the impact of the 2013 total ban on indoor smoking in Chile on hospitalizations and deaths of major cardiovascular events. The logarithm of the monthly hospitalization and death rates, standardized by age for every 100 000 inhabitants, were estimated for ischemic heart disease, acute myocardial infarction, strokes, and a composite outcome of ischemic heart diseases (which includes acute myocardial infarction) and strokes. In addition, interrupted time series with synthetic control groups were used to assess changes in levels and trends after the intervention. The total ban on indoor smoking caused significant reductions in death rates for the three diseases studied for age groups above 20 years old. In addition, there were substantial decreases in the post-intervention hospitalization rates for ischemic heart disease: for the 20–44 age group, the decrease was 8.7% compared to the pre-intervention period (p < .01). In comparison, such a reduction was 4% (p < .01) for the ≥65 age group. For acute myocardial infarction, the decrease was 11.5% (p < .01) for the 20–44 age group, while for stroke, it was a 1.2% (p < .01) decrease for the total population. It is estimated that the smoking ban averted 15.6% of the deaths compared with the synthetic control groups. The implementation of total smoke-free environments in Chile contributed to the reduction of mortality for main cardiovascular diseases. This study provides additional evidence of causality linking the policy to health outcomes. The total indoor smoking ban significantly affected age-standardized hospitalization and deaths. The number of deaths averted by this policy is estimated at approximately 4758 and 5256 for IHD and stroke, respectively, during the 2013–2017 period (15.6% fewer deaths than predicted by the synthetic control groups). The study contributes to the body of evidence that supports total indoor smoking bans.


  • The problem of estimation and forecasting of obesity prevalence using sparsely collected data

    by Luis Rojo-González, Jocelyn Dunstan, Cristóbal Cuadrado, Denisse Ávalos, Javier Moraga-Correa, Nelson Troncoso, Óscar C. Vásquez


  • Open Access

    Nowcasting methods to improve the performance of Respiratory Sentinel Surveillance: Lessons from the COVID-19 Pandemic

    by Sandra Flores-Alvarado, María Fernanda Olivares, Natalia Vergara, Christian García, Mauricio Canals, Cristóbal Cuadrado

    Respiratory diseases, including influenza and coronaviruses, pose recurrent global threats. This study delves into the respiratory surveillance systems, focusing on the effectiveness of SARI sentinel surveillance for total and severe cases incidence estimation. Leveraging data from the COVID-19 pandemic in Chile, we examined a 159-week period comparing census surveillance results of confirmed cases and hospitalizations, with sentinel surveillance carried out during the same period. Our analyses revealed a consistent underestimation of total cases and an overestimation of severe cases of sentinel surveillance. To address these limitations, we introduce a nowcasting model, improving the precision and accuracy of incidence estimates. Our findings are applicable beyond COVID-19, with implications for respiratory virus surveillance and early detection of respiratory epidemics. The nowcasting model offers real-time insights into an outbreak for public health decision-making, using the same surveillance data that is routinely collected. This approach enhances global preparedness for emerging respiratory diseases by the development of practical solutions with wide-ranging applications in public health.

  • Top Cited Papers
    Open Access

    What is the impact of forced displacement on health? A scoping review

    by Cristóbal Cuadrado, Matías Libuy, Rodrigo Moreno-Serra

    While there is a broad literature analysing the effects of migration on health, important knowledge gaps persist particularly on the causal effects of forced displacement on health outcomes. We undertake a scoping review of applied epidemiological, statistical and econometric studies examining causal health impacts of forced displacement, which initially identified 1454 studies from the health and social sciences disciplines published up to May 2021. Our study makes two key contributions. First, we offer a comprehensive overview of the evidence generated, methodologies adopted and analytical challenges faced by current research examining the causal relationship between forced displacement and health. Second, we present concrete examples of how key challenges around study design and estimation approaches influence the strength of the evidence-base on the topic, using as a case study the broad domain of reproductive health. We find that, beyond the increased mortality risk that can be attributed to forced displacement, most of the available empirical evidence for a wide range of health outcomes is prone to substantial bias, making it difficult to draw firm conclusions. Our synthesis of credible studies conducted in different settings indicates that current research practice in the field could be strengthened through selection of valid control groups and application of more appropriate causal inference methods. Our findings are useful to promote the generation of further evidence on the topic that can reliably inform the design of policies to protect the health of displaced populations.


  • Open Access

    Effectiveness and duration of a second COVID-19 vaccine booster

    by Alejandro Jara, Cristobal Cuadrado, Eduardo A. Undurraga, Christian García, Manuel Nájera, María Paz Bertoglia, Verónica Vergara, Jorge Fernández, Heriberto Garcia, Rafael Araos

    Using a prospective national cohort of 3.75 million individuals aged 20 or older, we evaluated the effectiveness against COVID-19 related ICU admissions and death of mRNA-based second vaccine boosters for four different three-dose background regimes: BNT162b2 primary series plus a homologous booster, and CoronaVac primary series plus an mRNA booster, a homologous booster, and a ChAdOx-1 booster. We estimated the vaccine effectiveness weekly from February 14 to August 15, 2022, by estimating hazard ratios of immunization over non-vaccination, accounting for relevant confounders. The overall adjusted effectiveness of a second mRNA booster shot was 88.2% (95%CI, 86.2-89.9) and 90.5% (95%CI 89.4-91.4) against ICU admissions and death, respectively. Vaccine effectiveness showed a mild decrease for all regimens and outcomes, probably associated with the introduction of BA.4 and BA.5 Omicron sub-lineages and immunity waning. The duration of effectiveness suggests that no additional boosters are needed six months following a second booster shot.